China (Mainland)
Moxifloxacin CAS NO.151096-09-2
- Min.Order: 10 Kilogram
- Payment Terms: L/C|D/A|D/P|T/T
- Product Details
Keywords
Quick Details
- ProName: Moxifloxacin
- CasNo: 151096-09-2
- Molecular Formula: C21H24FN3O4
- Appearance: White or almost white crystalline powd...
- Application: Moxifloxacin is used to treat a number...
- DeliveryTime: in one or two weeks after contract
- PackAge: 25kg per bag.Outside: carton or drum
- Port: any port of china
- ProductionCapacity: 50 Metric Ton/Month
- Purity: 98.5%
- Storage: Store in dry places and keep away from...
- Transportation: as your requirement
- LimitNum: 10 Kilogram
Superiority
Specification ProductName …
Details
| Product Name | Amoxicillin Trihydrate |
| CAS NO. | 151096-09-2 |
| Formual | C21H24FN3O4 |
| Standard | FCC/USP/BP/EP |
| EINECS No | 248-003-8 |
| Molecular weight | 401.44 |
| Packing | Inside: vacauumed aseptic PE bags, 25kg per bag. Outside: carton or drum Packages size can also be offered according to customer requirement |
| Purity | 98.5% |
| Appearance | White or almost white crystalline powder |
| Specific Optical Rotation | B/w – 125º and - 136º |
| PH | B/w 3.9 and 4.6 |
| Assay by HPLC | 98% ~102% |
| Stability and storage | Store in dry places and keep away from strong direct light |
| Uses | Moxifloxacin is used to treat a number of infections including: respiratory tract infections, cellulitis, anthrax, intraabdominal infections, endocarditis, meningitis, and tuberculosis. In the adult population its oral and intravenous is limited to the treatment of proven serious and life-threatening bacterial infections. The initial approval by the FDA (December 1999) encompassed the following indications: Acute Exacerbations of Chronic Bronchitis (AECB) (restricted use) Acute Bacterial Sinusitis (ABS) (restricted use) Community Acquired Pneumonia (CAP)(restricted use) |
